Characteristics of TCRζ, ZAP-70, and FcεRIγ gene expression in patients with T- and NK/T-cell lymphoma

DNA and Cell Biology

Volumn 34, Issue 3, 2015, Pages 201-207

  Liao, Ziwei ^a   Zhou, Lingling ^a   Wang, Chunyan ^b   He, Zhifeng ^c   Wang, Xu ^a   Luo, Xiaodan ^b   Chen, Shaohua ^a   Yang, Lijian ^a   Tan, Huo ^b   Li, Yangqiu ^a  

^a JINAN UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPSILON OPIATE RECEPTOR; FC EPSILON RECEPTOR TYPE 1 GAMMA; PROTEIN KINASE SYK; PROTEIN KINASE ZAP 70; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ZETA; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; ANTIGEN T CELL RECEPTOR, ZETA CHAIN; FCEPSILONRI GAMMA-CHAIN, HUMAN; IMMUNOGLOBULIN E RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; ZAP70 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CANCER GROWTH; CHILD; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOREGULATION; MALE; NK T CELL LYMPHOMA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T CELL LYMPHOMA; T LYMPHOCYTE ACTIVATION; ADOLESCENT; CELL CULTURE; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; NATURAL KILLER CELL; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; YOUNG ADULT;

3' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; AGED; CELLS, CULTURED; CHILD; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, IGE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; YOUNG ADULT; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 84923109025     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2014.2693     Document Type: Article

References (33)

1. Bajor-Dattilo, E.B., Pittaluga, S., and Jaffe, E.S. (2013). Pathobiology of T-cell and NK-cell lymphomas. Best Pract Res Clin Haematol 26, 75-87.
2. Call, M.E., Pyrdol, J., Wiedmann, M., and Wucherpfennig, K.W. (2002). The organizing principle in the formation of the T cell receptor-CD3 complex. Cell 111, 967-979.
3. Call, M.E., and Wucherpfennig, K.W. (2005). The T cell receptor: critical role of the membrane environment in receptor assembly and function. Annu Rev Immunol 23, 101-125.
4. Chauchet, A., Michallet, A.S., Berger, F., Bedgedjian, I., Deconinck, E., Sebban, C., et al. (2012). Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma. J Hematol Oncol 5, 27.
5. Chen, S., Zha, X., Yang, L., Li, B., Liye, Z., and Li, Y. (2011). Deficiency of CD3gamma, delta, epsilon, and zeta expression in T cells from AML patients. Hematology 16, 31-36.
6. Chen, X., Woiciechowsky, A., Raffegerst, S., Schendel, D., Kolb, H.J., and Roskrow, M. (2000). Impaired expression of the CD3-zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis. Br J Haematol 111, 817-825.
7. Chen, Y., Liu, S.C., Shen, Q., Zha, X.F., Zheng, H.T., Yang, L.J., et al. (2013). Differential gene expression profiles of PPP2R5C-siRNA-treated malignant T cells. DNA Cell Biol 32, 573-581.
8. Chowdhury, B., Tsokos, C.G., Krishnan, S., Robertson, J., Fisher, C.U., Warke, R.G., et al. (2005). Decreased stability and translation of T cell receptor zeta mRNA with an alternatively spliced 3′-untranslated region contribute to zeta chain down-regulation in patients with systemic lupus erythematosus. J Biol Chem 280, 18959-18966.
9. Enyedy, E.J., Nambiar, M.P., Liossis, S.N., Dennis, G., Kammer, G.M., and Tsokos, G.C. (2001). Fc epsilon receptor type I gamma chain replaces the deficient T cell receptor zeta chain in T cells of patients with systemic lupus erythematosus. Arthritis Rheum 44, 1114-1121.
10. Fargnoli, M.C., Edelson, R.L., Berger, C.L., Chimenti, S., Couture, C., Mustelin, T., et al. (1997). Diminished TCR signaling in cutaneous T cell lymphoma is associated with decreased activities of Zap70, Syk and membrane-associated Csk. Leukemia 11, 1338-1346.
11. Fischer, A., Picard, C., Chemin, K., Dogniaux, S., Deist, F., and Hivroz, C. (2010). ZAP70: a master regulator of adaptive immunity. Semin Immunopathol 32, 107-116.
12. Gimenes-Teixeira, H.L., Lucena-Araujo, A.R., Dos Santos, G.A., Zanette, D.L., Scheucher, P.S., Oliveira, L.C., et al. (2013). Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia. Exp Hematol Oncol 2, 10.
13. Grulich, A.E., and Vajdic, C.M. (2005). The epidemiology of non-Hodgkin lymphoma. Pathology 37, 409-419.
14. Guy, C.S., and Vignali, D.A.A. (2009). Organization of proximal signal initiation at the TCR:CD3 complex. Immunol Rev 232, 7-21.
15. Huang, L., Chen, S., Zha, X., Yang, L., Li, B., Yu, Z., et al. (2012). Expression feature of CD3, FcεRIγ, and Zap-70 in patients with chronic lymphocytic leukemia. Hematology 17, 71-75.
16. Jaffe, E.S., Krenacs, L., and Raffeld, M. (2003). Classification of cytotoxic T-cell and natural killer cell lymphomas. Semin Hematol 40, 175-184.
17. Jain, S., Zain, J., and O'Connor, O. (2012). Novel therapeutic agents for cutaneous T-Cell lymphoma. J Hematol Oncol 5, 24.
18. Kim, J.R., Irie, A., Tsukamoto, H., and Nishimura, Y. (2006). A role of kinase inactive ZAP-70 in altered peptide ligand stimulated T cell activation. Biochem Biophys Res Commun 341, 19-27.
19. Knowles, D.M. (1999). Immunodeficiency-associated lymphoproliferative disorders. Mod Pathol 12, 200-217.
20. Krishnan, S., Warke, V.G., Nambiar, M.P., Tsokos, G.C., and Farber, D.L. (2003). The FcR gamma subunit and Syk kinase replace the CD3 zeta-chain and ZAP-70 kinase in the TCR signaling complex of human effector CD4 T cells. J Immunol 170, 4189-4195.
21. Kuhns, M.S., and Davis, M.M. (2007). Disruption of extracellular interactions impairs T cell receptor-CD3 complex stability and signaling. Immunity 26, 357-369.
22. Li, B., Liu, S., Niu, Y., Fang, S., Wu, X., Yu, Z., et al. (2012a). Altered expression of the TCR signaling related genes CD3 and FcεRIγ in patients with aplastic anemia. J Hematol Oncol 5, 6.
23. Li, B., Niu, Y., Liu, S., Yu, W., Chen, J., Wu, L., et al. (2012b). A change in CD3γ, CD3δ, CD3, and CD3ζ gene expression in T-lymphocytes from benzene-exposed and benzene-poisoned workers. J Immunotoxicol 9, 160-167.
24. Li, Y. (2008). Alterations in the expression pattern of TCR zeta chain in T cells from patients with hematological diseases. Hematology 13, 267-275.
25. Li, Y.Q., Chen, S.H., Yang, L.J., Chen, S., Lin, C.L., Wang, L., et al. (2011). Change in expression pattern of TCR-CD3 complex in patients with multiple myeloma. Hematology 16, 143-150.
26. Nambiar, M.P., Enyedy, E.J., Warke, V.G., Krishnan, S., Dennis, G., Kammer, G.M., et al. (2001). Polymorphisms/mutations of TCR-zeta-chain promoter and 3′ untranslated region and selective expression of TCR zeta-chain with an alternatively spliced 3′ untranslated region in patients with systemic lupus erythematosus. J Autoimmun 16, 133-142.
27. Smedby, K.E., Hjalgrim, H., Askling, J., Chang, E.T., Gregersen, H., Porwit-MacDonald, A., et al. (2006). Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 98, 51-60.
28. Tsuzaka, K., Onoda, N., Yoshimoto, K., Setoyama, Y., Suzuki, K., Pang, M., et al. (2002). T-cell receptor zeta mRNA with an alternatively spliced 3′ untranslated region is generated predominantly in the peripheral blood T cells of systemic lupus erythematosus patients. Mod Rheumatol 12, 167-173.
29. Whiteside, T.L. (2004). Down-regulation of zeta-chain expression in T cells: a biomarker of prognosis in cancer? Cancer Immunol Immunother 53, 865-878.
30. Xue, F., Li, H., Zhang, J., Lu, J., Xia, Y., and Xia, Q. (2013). miR-31 regulates interleukin 2 and kinase suppressor of ras 2 during T cell activation. Genes Immun 14, 127-131.
31. Zelenetz, A.D., Gordon, L.I., Wierda, W.G., Abramson, J.S., Advani, R.H., Andreadis, C.B., et al. (2014). Non-Hodgkin's lymphomas, Version 4.2014. J Natl Compr Canc Netw 12, 1282-1303.
32. Zha, X.F., Chen, S.H., Yang, L.J., Shi, L., Li, B., Wu, X.L., et al. (2012a). Upregulated TCRζ enhances interleukin-2 production in T-cells from patients with CML. DNA Cell Biol 31, 1628-1635.
33. Zha, X.F., Yan, X.J., Shen, Q., Zhang, Y.P., Wu, X.L., Chen, S.H., et al. (2012b). Alternative expression of TCR zeta related genes in patients with chronic myeloid leukemia. J Hematol Oncol 5, 11.